3-Bromo-5-[5-(chloromethyl)-1,3,4-oxadiazol-2-yl]pyridine → 1-{[5-(5-Bromo-3-pyridinyl)-1,3,4-oxadiazol-2-yl]methyl}-4-chloro-2-propyl-1H-indole-5-carbonitrile
Reaction equation
[Cl:1][C:2]1[C:10]([C:11]#[N:12])=[CH:9][CH:8]=[C:7]2[C:3]=1[CH:4]=[C:5]([CH2:13][CH2:14][CH3:15])[NH:6]2.[Br:16][C:17]1[CH:18]=[N:19][CH:20]=[C:21]([C:23]2[O:24][C:25]([CH2:28]Cl)=[N:26][N:27]=2)[CH:22]=1>>[Br:16][C:17]1[CH:22]=[C:21]([C:23]2[O:24][C:25]([CH2:28][N:6]3[C:7]4[C:3](=[C:2]([Cl:1])[C:10]([C:11]#[N:12])=[CH:9][CH:8]=4)[CH:4]=[C:5]3[CH2:13][CH2:14][CH3:15])=[N:26][N:27]=2)[CH:20]=[N:19][CH:18]=1Participants
3
Procedure
Synthesized as described in Example 4 from 4-chloro-2-propyl-1H-indole-5-carbonitrile and 3-bromo-5-[5-(chloromethyl)-1,3,4-oxadiazol-2-yl]pyridine: 1H NMR (400 MHz, DMSO-d6) δ 9.03 (d, J=1.3 Hz, 1 H), 8.94 (d, J=2.0 Hz, 1 H), 8.46 (s, 1 H), 7.97 (s, 1 H), 7.81 (d, J=8.5 Hz, 1 H), 7.61 (d, J=8.5 Hz, 1 H), 5.96 (s, 2 H), 2.95-2.87 (m, 2 H), 1.75-1.48 (m, 2 H), 0.93 (t, J=7.3 Hz, 3 H); MS (ES) m/z 457 (M+1).
Workup
- customSynthesized
Sources & evidence
- ORD record
- ord-9fce62de81804375b6151ecd7409dbf8
- Source dataset
- uspto-grants-2011_09
- Patent number
- US08026262B2
Reaction notes
Loading…